ArticleInternational journal of hematology2023

Clinical management of second-generation tyrosine kinase inhibitor therapy in patients with newly diagnosed chronic myeloid leukemia in the chronic phase, focusing on age and dose effects.

Michihide Tokuhira et al.PubMed ↗Publisher ↗

No numbers read from the abstract.